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Objective: Evidence-based medicine is emerging as a new paradigm for medical
practice. The purpose of this study was to evaluate the amount and quality of
scientific evidence supporting principles that are currently applied for cardiopulmo-
nary bypass performance.
Methods: A survey of all German departments of cardiac surgery regarding cardio-
pulmonary bypass performance disclosed major differences. Consequently, for 48
major principles of cardiopulmonary bypass performance, relevant Medical Subject
Headings were identified, and a literature search of the Medline database was
performed. Two sequentially applied sets of inclusion-exclusion criteria were se-
lected to assess the best available evidence.
Results: Thirty-three thousand articles relating to the subject were identified.
Among these, 1500 fulfilled the first set of inclusion criteria: meta-analysis of
(randomized) controlled clinical trials and in vitro and animal studies. Rigorous
methodological criteria were then applied to further select remaining publications.
Ultimately, 225 articles referring to major cardiopulmonary bypass principles were
identified as providing the best available evidence. These were graded according to
their methodological rigor (susceptibility to bias). The scientific evidence on the
investigated cardiopulmonary bypass principles did not prove to be of a high enough
level to allow general recommendations to be made.
Conclusions: The scientific data concerning the effectiveness and safety of key
principles of cardiopulmonary bypass are insufficient in both amount and quality of
scientific evidence to serve as a basis for practical, evidence-based guidelines.
The first successful clinical application of cardiopulmonary bypass(CPB) by John Gibbon in 1953 revolutionized cardiac surgicalprocedures. Today, CPB is routinely used for various cardiac andnoncardiac surgical operations and appears to be a safe procedure.However, the unresolved problems and limitations of CPB are ob-vious in daily clinical practice. Bleeding disorders, systemic inflam-
matory reactions, multiorgan failure, neurologic deficits, permanent intellectual
impairment, and pulmonary dysfunction are only some examples of the hazards of
modern CPB.
Improving the quality of medical care by establishing medical practice guidelines
has been vigorously promoted by the US health care system.1 The responsible
medical societies have developed practice guidelines on the basis of evidence-based
medicine criteria for various procedures.2-6 Thus a new paradigm of medical
practice is emerging. Evidence-based medicine de-emphasizes intuition and unsys-
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tematic clinical experience as sufficient grounds for clinical
decision making and stresses the examination of evidence
from clinical and experimental research.7
A survey concerning principles of CPB performance was
sent to all German centers of cardiac surgery. The obtained
results disclosed significant differences regarding CPB per-
formance. As a consequence, the Working Group on Extra-
Corporeal Circulation and Mechanical Ventricular Assist
Devices of the German Society for Thoracic and Cardio-
vascular Surgery tried to develop a consensus document for
the clinical application of CPB. Forty-eight major principles
of CPB were formulated into questions to be addressed by
a review of the scientific literature. The issues of interest
covered nearly all relevant aspects of CPB (eg, optimum
activated clotting time for routine CPB or during hypother-
mic circulatory arrest; anticoagulation management by the
use of aprotinin; myocardial protection; technical safety
aspects; pump flow rate, blood pressure, or both, for the
different degrees of hypothermia; and washout of toxic
metabolites from CPB material). In case of clinical studies,
the key parameters for scientific evaluation of the investi-
gated principles concentrated on patients’ clinical outcomes
and not on surrogate parameters.
Because it is impossible to deal adequately with each of
the 48 questions within the scope of an article, the topics
and our results are presented here in tabular form (Tables 1
and 2). As an example of our methodological approach, we
selected a sample question (topics 38 and 39) that will be
described in detail in the appropriate sections.
The sample question was, “What is the appropriate acid-
base management strategy for optimum cerebral protection
in adults with respect to moderate respiratory deep hypo-
thermia?”
The clinical rationale behind this question was that neu-
rologic injury and postoperative cognitive dysfunction ap-
pear to be the most frequent complications of CPB proce-
dures. From 1970 to 1973, 8% of patients subjected to CPB
died after a neurologic event; by contrast, from 1980 to
1983, 20% of postoperative deaths were related to severe
neurologic injury.8 More recently, a longitudinal assessment
of neurocognitive function after coronary artery bypass
grafting was reported.9 These authors demonstrated an in-
cidence of cognitive decline of 53% at discharge and of
42% after 5 years.
Although the cause of postoperative central nervous sys-
tem dysfunction in patients subjected to CPB is multifacto-
rial, microgaseous and solid emboli are particularly culpa-
ble and seem to be influenced by different brain perfusion
rates of pH management.
Scientific and Pathophysiologic Background
The ability to control a patient’s body temperature within a
wide range is one of the most important therapeutic modal-
ities made available by the application of CPB. One of the
most frequently discussed aspects of clinical hypothermia is
the appropriate acid-base management strategy during cool-
ing and rewarming. The term alpha-stat indicates an acid-
base management in which the net charge (dissociation) of
proteins remains constant as the temperature changes. The
alternative method is termed pH-stat (ie, maintaining pH
value constant at varying temperatures).
Alpha-stat management will result in lower cerebral flow
compared with pH-stat management. Intact cerebral auto-
regulation has been demonstrated in human subjects after
alpha-stat strategy at temperatures from 21°C to 29°C.10 In
contrast, cerebral autoregulation was abolished, and it var-
ied, depending on cerebral blood flow, when pH-stat was
used.11 In deep hypothermia the normal vascular responses
are lost, and cerebral blood flow is dependent on the per-
fusion pressure with uncoupling of flow and metabolism.
During moderate hypothermia, the variations in PCO2 be-
tween the different acid-base managements are only minor
and do not seem to be clinically relevant.12 In contrast, the
difference in PCO2 during deep hypothermia approaches 80
mm Hg between the two acid-base strategies. The increased
cerebral blood flow associated with pH-stat strategy may
increase the risk of microemboli, cerebral edema, or high
intracranial pressure. On the other hand, increased brain
perfusion may result in improved cerebral cooling before
circulatory arrest.
This article has two main aims: (1) to summarize the
results obtained regarding the scientific quality of the re-
viewed publications and (2) to determine the scientific basis
of currently applied CPB principles.
Methods
We performed a systematic search of the Medline database for
Medical Subject Headings referring to the various principles of
CPB in the past 20 years. The appropriate selection, combination,
and use of the Medical Subject Headings were cross-checked by
two other members of our working group to ensure as complete a
search as possible.
Step 1: Scientific Level of the Reviewed Literature
All abstracts of articles identified by the search were reviewed by
at least four members of the working group. Articles were selected
for further review if one or more of the following criteria was met:
● Articles were available in English, French, Italian, or Spanish
language
● Articles used a randomized study design
● A control group was available
● Articles were editorials and reviews in peer-reviewed jour-
nals
● Articles were meta-analyses
● The same criteria were applied to in vitro studies and animal
studies
All reference lists were checked for publications missed in the
Medline search.
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TABLE 1. Summarized results
Subject
Scientific level of literature
Parameters determining clinical outcome Class*I II III IV
Technical equipment
1. Centrifugal vs roller pump 0 4 1 0 sp, trans, vent, icu IIb
2. Pulsatile vs nonpulsatile perfusion 0 5 7 0 sp, mort, mi, morb, neur IIb
3. Heparin-coated surfaces 0 5 3 0 sp, trans, vent, icu, hosp, mort, morb,
neur, arr, mi, vent
IIb
4. Toxicity of PVC 0 0 2 0 sp III
5. Closed vs open cardiotomy reservoirs 0 1 2 1 sp, trans, icu, hosp III
6. Arterial filter systems 0 0 6 0 sp, neur III
7. Autotransfusion vs cell separation 0 1 1 1 sp, trans IIb
Preparation of CPB
8. Volume substitution before CPB 0 4 0 0 sp, trans III
9. Priming in adults 0 10 1 0 sp, trans IIb
10. Priming in infants and neonates 0 0 3 2 sp, trans IIb
11. Application of aprotinin 3 1 2 0 sp, re, trans, mi, mort, all, byp IIa
12. Additive drugs in priming solution 0 4 0 2 sp, cvi, vent III
13. Temperature of priming solution na na na na III
14. Perfusion volume na na na na III
15. CO2 rinsing of arterial filters na na na na III
16. Protection of tubes by connectors na na na na III
Performance and supervision of CPB
17. How should ACT be measured? 0 2 0 3 sp IIa
18. Other coagulation parameters besides ACT
during CPB
0 5 7 0 sp, trans III
19. Level of ACT during CPB 0 3 2 0 sp, trans IIb
20. Level of ACT for hemodilution during CPB 0 1 1 2 sp, trans III
21. Level of ACT with aprotinin during CPB 1 1 0 1 sp, byp III
22. Level of ACT with aprotinin in DHCA 0 1 3 0 sp, trans, rf III
23. Heparin administration 0 1 0 0 sp, trans III
24. Heparin resistance 0 0 3 0 sp IIb
25. Antithrombin III deficiency 0 0 3 0 sp, trans IIa
26. Protamine application 0 2 2 0 sp, trans IIb
27. Effects of priming solution on platelet function 0 2 0 0 sp, trans III
28. Effects of oxygenator type on platelet function 0 1 4 0 sp, trans III
29. Effects of pump type on platelet function 0 2 1 0 sp III
30. Platelet-rich plasmapheresis and transfusion
requirements
0 3 0 0 sp, trans III
31. Desmopressin acetate and transfusion
requirements
0 4 0 0 sp, trans IIb
32. Indicators for platelet transfusion 0 1 3 0 sp, trans III
33. Patient selection for tranexamic acid or 
aminocaproic acid treatment
0 5 3 0 sp, mi, cvi, pe, dvt, trans IIb
34. Dosage of tranexamic acid or  aminocaproic
acid
0 2 0 0 sp, trans, cvi, dvt, mi IIb
35. Effects of tranexamic acid or  aminocaproic
acid on bleeding
1 5 0 0 sp, trans, mi, cvi, mort
a) in elective patients IIb
b) in patients with increased risk of bleeding sp, trans, cvi, mi, dvt IIb
36. pH strategy during DHCA in pediatric cardiac
surgery
0 1 2 2 sp, con, vent, icu, neur IIa
37. pH strategy during moderate hypothermia in
pediatric cardiac surgery
na na na na III
38. pH strategy during DHCA in adult cardiac
surgery
na na na na III
39. pH strategy during moderate hypothermia in
adult cardiac surgery
0 5 1 0 sp, mort, mi, cvi, arr, rf, neur, vent, icu IIa
40. Myocardial protection 0 7 3 1 sp, mort, mi, cvi, rf, icu, vent III
(Continued on next page)
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Step 2
The scientific quality of the manuscripts was assessed by at least
four members of the working group regarding structure and con-
tent.
Manuscripts were selected for further review if they included
the following:
● A background review of the subject
● An explicit statement of objectives
● A detailed description of the type and selection of subjects
and procedures
● A detailed description of applied methods
● A description of quantitative methods
● An exact description of the randomization procedure (eg,
centralized, pharmacy controlled, prenumbered, or coded)
● An adequate description of executing or measuring the pre-
dictor-outcome variable
● A comparison with alternative technologies and procedures
● A detailed description of clinical end points
All articles that did not meet these criteria were checked for further
important information, in which case they were also selected for
review. If no article fulfilled the mentioned criteria, articles of
lesser scientific quality were selected for review. Articles were
excluded if any of the following were true:
● Study results were summarized in high-quality reviews se-
lected for evaluation of their scientific level
● The same data had evidently been published twice
● The statistical methods were inadequate
● The selection of subjects, procedures, or both, was inade-
quate
Step 3
According to the methodological rigor, the selected articles were
classified according to their scientific level:
● Level I: Investigations yielding clear evidence that a given
procedure or treatment is useful and effective (large random-
ized prospective trials with low false-positive [] and low
false-negative [] errors and high-quality meta-analysis)
● Level II: Investigations that do not provide clear scientific
evidence about the usefulness, efficacy, or both of a proce-
dure or treatment (eg, small sample size and lack of random-
ization)
● Level III: Investigations that do not provide scientific evi-
dence about the usefulness, efficacy, or both, of a procedure
or treatment (eg, trials without appropriate controls)
● Level IV: In vitro or animal studies and nonsystematic re-
views
All in vitro and animal studies selected for inclusion in the study
were classified as level IV without respect to the scientific design
and the number and quality of interventions or statistical methods.
This approach was chosen in view of the limited application of
in vitro and animal study results to the clinical situation.
The level of scientific evidence assigned to each article was
cross-checked by two other members of the working group. Any
disagreements were resolved by means of consensus. For all arti-
TABLE 2. Abbreviations used in Table 1
trans Transfusion requirements, including coagulation factors
mort Mortality
morb Morbidity
mi Perioperative myocardial infarction
neur Neurologic-cognitive dysfunction




dvt Deep venous thrombosis
con Convulsion
arr Arrhythmia requiring treatment
lco Low cardiac output
re Rethoracotomy for bleeding
vent Ventilation dependence




qual Quality of life
DHCA Deep hypothermic cardiac arrest
ACT Activated clotting time
TABLE 1. Cont’d
Subject
Scientific level of literature
Parameters determining clinical outcome Class*I II III IV
41. Optimum core temperature 0 10 1 0 sp, mort, mi, cvi, neur, re, trans, lco III
42. Optimum temperature gradient 0 0 0 2 sp III
43. Optimum mean arterial perfusion pressure and
flow
0 2 4 0 sp, neur, mort, mi, cvi, qual III
44. Selective cerebral perfusion 0 0 5 1 sp, mort, neur III
45. Efficacy of different methods of selective
cerebral perfusion
0 0 5 1 III
Documentation, quality assurance, personal resources
46. Automatic data documentation 0 0 5 6 na III
47. Quality assurance 0 0 3 11 na III
48. Perfusionist’s education 0 0 6 0 na III
For complete abbreviation list, see Table 2. na, No scientific publication available.
* Classification of the scientific evidence of the examined principle.
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cles, the adequate use of statistical methods was critically assessed
and discussed with collaborating medical statisticians, for exam-
ple:
● Assurance of comparability of study groups
● Data analysis according to the primary study protocol
● Whether paired tests for paired data were used
● Differentiation between correlation and regression
● Correct calculation and interpretation of the correlation co-
efficient (r value)
● Correct calculation and interpretation of the P value
Step 4: Classification of the Scientific Evidence on
CPB Principles
After all relevant articles had been graded with respect to their
scientific level, the investigated principle (procedure or treatment)
was classified according to a modification of the American Heart
Association (AHA)/American College of Cardiology (ACC)
guidelines for scientific evidence.2,4,6
● Class I: Principle for which there is clear evidence, scientific
agreement, or both, that a given procedure or treatment is
useful and effective
● Class II: Principle for which there is conflicting scientific
evidence, a divergence of opinion, or both, about the useful-
ness, efficacy, or both, of a procedure or treatment
● Class IIa: Weight of evidence, opinion, or both, is in favor of
the usefulness, efficacy, or both, of a procedure or treatment
● Class IIb: The usefulness, efficacy, or both, is less well
established by means of evidence, opinion, or both, for a
procedure or treatment
● Class III: Principle for which there is no sufficient scientific
evaluation about the usefulness, efficacy, or both, of a pro-
cedure or treatment, in vitro studies, and animal studies
If a cardiac surgeon is to be convinced to critically assess his
daily practice, more is generally required than advantages achieved
by means of surrogate parameters. Therefore, we gave priority to
studies analyzing different techniques or procedures with respect
to patients’ clinical outcomes (eg, mortality, morbidity, special
organ function, transfusion requirements, length of stay at the
intensive care unit, and overall hospital time; Table 1).
Table 1 contains a brief version of the questions formulated
concerning CPB principles, scientific level of reviewed articles,
selected clinical end points, and their classification on the basis of
the scientific evidence. In case no scientific articles were available
for a specific question, “not available” was indicated. The single
results of the scientific level of the evaluated manuscripts are
available on our Web site (address given in the appendix).
Table 3 depicts the selection of key words, their combination,
and the number of articles identified in connection with our sample
question regarding acid-base management in adults.
Results
A total of 33,000 articles identified were retrieved. Of these,
1500 articles fulfilled the criteria for the first step of the
selection procedure. The 225 articles with the best scientific
evidence available were classified according to the level of
their scientific evidence on the basis of their methodological
rigor. Table 1 depicts the scientific level of the evaluated
literature.
Many studies showed methodological problems (eg, im-
precise study design or inappropriate statistical methods).
As a result, most of the classified articles showed divergent
results regarding individual principles of CPB performance.
Thus, the scientific evidence regarding CPB principles
could not be conclusive in these cases.
Discussion
Since its first successful clinical application in 1953, the
CPB technique has revolutionized cardiac surgery. Today,
CPB is routinely used for various cardiac and noncardiac
operations with good clinical results. Thus far no systematic
review of the available literature has been undertaken to
determine the amount and quality of scientific information.
On the basis of our scientific evaluation of the current
literature on 48 principles of CPB, not a single condition
was of sufficient scientific merit to conclude that we were
dealing with a principle for which there is clear evidence,
scientific agreement, or both, that a given procedure or
treatment is useful and effective.
Ideally, for each procedure or intervention, there should
be direct and clear evidence from one or more studies that
relate the application of this procedure (compared with
specified alternatives) to the health outcomes of interest of
a specific patient. However, rapid changes in medical prac-
tice, ethical considerations, and practical reasons make this
TABLE 3. Key word selection for the sample question




pH management 0 1,481
pH management Cardiopulmonary bypass 80
pH management Extracorporeal circulation 95
pH management Heart-lung machine 0
pH management Cerebral blood flow 57
pH management Temperature 146
pH management Hypothermia 97
pH management Hypothermic cardiac arrest 1
pH management Hypothermic circulatory arrest 14
pH management Cardiac surgery 26
pH management Heart surgery 59
pH-stat 0 483
pH-stat Cardiac surgery 15
pH-stat Heart surgery 29
pH-stat Extracorporeal circulation 53
pH-stat Cardiopulmonary bypass 58
pH-stat Heart-lung machine 1
pH-stat Circulatory arrest 15
Alpha-stat 0 139
Alpha-stat Cardiac surgery 24
Alpha-stat Heart surgery 56
Alpha-stat Extracorporeal circulation 100
Alpha-stat Cardiopulmonary bypass 104
Alpha-stat Heart-lung machine 1
Alpha-stat Circulatory arrest 22
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desirable principle of patient care impossible to achieve.
Thus, the limited scientific evaluation of current medical
practice represents a general phenomenon and not one that
is specific to the cardiothoracic surgical community.
Discussion of Our Sample Question
The sample question was, “What is the appropriate acid-
base management for optimal cerebral protection in adults
with respect to moderate respiratory deep hypothermia?”
The study design and content of 124 articles identified
were reviewed. For 42 original contributions, the scientific
value was assessed. Six articles were selected for classifi-
cation of the scientific evidence on the question as to which
pH-management strategy should be used for moderate hy-
pothermia in adults.12-17 Although study design and statis-
tical evaluation revealed some shortcomings, 5 of the con-
tributions achieved scientific level II.12-16 From this, the
conclusion could be drawn that alpha-stat management is
associated with a decreased incidence of postoperative ce-
rebral dysfunction without negatively affecting other organs
in adult patients subjected to moderate hypothermia and
prolonged CPB time.13-16 This conclusion contrasted with
data reported by Bashein and colleagues (scientific level
II).12 However, they used bubble oxygenators without arte-
rial filters in their study, which may imply significant influ-
encing factors. On the basis of the articles selected for
review, the scientific evidence of this CPB principle was
classified as IIa. Postoperative cerebral dysfunction is ob-
viously affected by underlying patient comorbidity. Thus,
whether our conclusion can be applied to patients with
preexisting cerebrovascular disease or uncontrolled hyper-
tension remains unclear, and the scientific background is
lacking. Therefore, we do not believe that our conclusion
can be used as a general recommendation. This demon-
strates that basic elements of CPB performance do not meet
evidence-based medicine criteria.
As for the question of which pH-management strategy
should be applied to adults undergoing deep hypothermic
arrest, no valid scientific data currently exist. We selected
this example to demonstrate that there is a pressing need to
apply evidence-based medicine principles to CPB perfor-
mance.
Thousands of publications cover the issue of CPB per-
formance. However, the quality of most articles in other
medical journals does not meet basic scientific criteria.18
After examining the quality of medical knowledge, other
authors reported that only 15% of medical interventions are
supported by solid scientific evidence.19
Although the quality of statistical analysis has improved
and the application of more complex statistical procedures
has increased during the past decades, imperfect study de-
sign and inadequate analysis remain an unresolved prob-
lem.20 Articles now report larger numbers of analyzed cases
than previously, yet the use of methods that aim to control
type I error is rare.21 True randomization requires exact
evaluation of inclusion and exclusion criteria before a strata
or blocked randomization protocol. In many publications
the term “randomized” is used for clinical trial, although the
investigation applied systematic allocation.20 This condition
limits the a priori scientific value of the study. For a scien-
tific evaluation of CPB principles, more concise study de-
signs and appropriate statistical evaluation seem to be man-
datory.
Limitations of the Study
Dickersin and colleagues22 examined the sensitivity and
precision of Medline searches for randomized trials. They
concluded that although the indexing terms available for
searching Medline have improved, the sensitivity “still re-
mains unsatisfactory.”
For this study, the appropriate use, selection, and com-
bination of Medical Subject Headings were cross-checked
by two other members of our working group. In addition,
currently available monographs dealing with the issue of
CPB were reviewed for missing publications. All original
contributions and reviews retrieved in our search were also
checked for missing articles. However, we cannot exclude
the possibility that important contributions failed to come to
our attention.
In contrast to the Task Force Committee of the AHA and
ACC, our purpose in undertaking this investigation could
not be the development of guidelines for CPB performance
for the following reasons:
1. Our Working Group on Extra-Corporeal Circulation
does not have the logistic and personnel requirements
available to the AHA/ACC committees.
2. For most CPB principles, the scientific background is
not conclusive enough to allow general recommenda-
tions. Therefore, recommendations should be based
on a consensus of numerous expert opinions on CPB
in combination with a review of the literature.
We encourage our colleagues to improve the clinical results
achievable with the application of CPB by expanding our
limited knowledge of current practice using the criteria of
evidence-based medicine. The scientific quality of CPB
performance would improve if the societies of cardiotho-
racic surgeons could initiate large, prospective, randomized
trials evaluating special CPB conditions.
David Eddy, professor of health policy and management
at Duke University, who began his medical life as a cardio-
thoracic surgeon, became a leader in the field of evidence-
based medicine, and trained other physicians to achieve
consensus for medical practice, stated the following in
1991: “Get doctors to understand how much they need
reliable information. What could be worse than two millen-
nia spent making life and death decisions with inadequate
information?”
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The list of articles classified according to their scientific level can
be found in the Internet at our Web site: www.herzchir.mu-
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